IBTK and psoriasis: The finding that BTKi attenuated TLR7-driven psoriasis-like inflammation in mice, most likely by acting on innate immune cells (Al-Harbi et al., 2020; Nadeem et al., 2020), points to BTKi as a promising therapeutic option.